Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
NAAS Rating: 5.03 new
Vol. 3, Issue 3 (2014)

Effect of overweight on the level of transforming growth factor in patients with purulent-destructive forms of chronic nonspecific pulmonary diseases

M.A. Mindrul
Patients with purulent-destructive forms of non-specific COPD under study have been examined on the question of the systemic level of the active form of TGF-β1. It was found that the laboratory test index of the male group of patients with such disease is currently increased in blood serum. Obese patients with purulent-destructive forms of COPD have displayed an extremely high level of the active form of TGF-β1. Clinical use of Acarbosum (Glucobay) as part of complex therapy of purulent-destructive forms of COPD in males with obesity has proved an antifibrotic effect which facilitated the reduction of an active form of TGF-β1 in blood serum.
Pages: 18-20  |  885 Views  4 Downloads
How to cite this article:
M.A. Mindrul. . The Pharma Innovation Journal. 2014; 3(3): 18-20.
Journals List Click Here Research Journals Research Journals
Call for book chapter
The Pharma Innovation Journal